INS and obesity disorder: Adiponectin for example, an anti-inflammatory adipokine, which is reduced in obesity and T2DM [24], has been shown to increase insulin sensitivity and to improve vascular function by reducing TNF-α-stimulated expression of endothelial adhesion molecules and monocyte attachment [25–27].